Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Recurrence and ESR1[original query] |
|---|
| Estrogen receptor alpha gene variants and major depressive episodes. Journal of affective disorders 2012 Feb 136 (3): 1222-6. Ryan Joanne, Scali Jacqueline, Carrière Isabelle, Peres Karine, Rouaud Olivier, Scarabin Pierre-Yves, Ritchie Karen, Ancelin Marie-Lau |
| ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer. Breast cancer research and treatment 2015 Nov . Leyland-Jones Brian, Gray Kathryn P, Abramovitz Mark, Bouzyk Mark, Young Brandon, Long Bradley, Kammler Roswitha, Dell'Orto Patrizia, Biasi Maria Olivia, Thürlimann Beat, Harvey Vernon, Neven Patrick, Arnould Laurent, Maibach Rudolf, Price Karen N, Coates Alan S, Goldhirsch Aron, Gelber Richard D, Pagani Olivia, Viale Giuseppe, Rae James M, Regan Meredith M, |
| The distribution pattern of ERa expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen. Clinical and experimental medicine 2016 May . Babyshkina Nataliya, Vtorushin Sergey, Zavyalova Marina, Patalyak Stanislav, Dronova Tatyana, Litviakov Nikolay, Slonimskaya Elena, Kzhyshkowska Julia, Cherdyntseva Nadejda, Choynzonov Evge |
| Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer. Gynecologic oncology 2016 Mar . Backes Floor J, Walker Christopher J, Goodfellow Paul J, Hade Erinn M, Agarwal Garima, Mutch David, Cohn David E, Suarez Adrian |
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy.
Cancer research 2016 Oct . Ingle James N, Xie Fang, Ellis Matthew J, Goss Paul E, Shepherd Lois E, Chapman Judith-Anne W, Chen Bingshu E, Kubo Michiaki, Furukawa Yoichi, Momozawa Yukihide, Stearns Vered, Pritchard Kathleen I, Barman Poulami, Carlson Erin E, Goetz Matthew P, Weinshilboum Richard M, Kalari Krishna R, Wang Liew |
| [Genetic risk factors for recurrence-free urolithiasis in the russian population]. Urologiia (Moscow, Russia : 1999) 2016 Aug (4): 20-23. Apolikhin O I, Sivkov A V, Konstantinova O V, Slominsky P A, Tupitsyna T V, Kalinichenko D |
| Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness. PloS one 2017 12 (10): e0185447. Robles-Fernandez Inmaculada, Martinez-Gonzalez Luis Javier, Pascual-Geler Manrique, Cozar Jose Manuel, Puche-Sanz Ignacio, Serrano Maria Jose, Lorente Jose Antonio, Alvarez-Cubero Maria Jes |
| A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ER? expression. Scientific reports 2018 10 8 (1): 16000. Watanabe Kenji, Yamamoto Shigeru, Sakaguti Syuiti, Isayama Keishiro, Oka Masaaki, Nagano Hiroaki, Mizukami Yoic |
| Liquid biopsy prediction of axillary lymph node metastasis, cancer recurrence, and patient survival in breast cancer: A meta-analysis. Medicine 2018 Oct 97 (42): e12862. Lee Ju-Han, Jeong Hoiseon, Choi Jung-Woo, Oh Hwa Eun, Kim Young-S |
| ESR1 mutations in metastatic lobular breast cancer patients. NPJ breast cancer 2019 3 5 9. Desmedt Christine, Pingitore Julien, Rothé Françoise, Marchio Caterina, Clatot Florian, Rouas Ghizlane, Richard François, Bertucci François, Mariani Odette, Galant Christine, Fribbens Charlotte, O'Leary Ben, van den Eynden Gert, Salgado Roberto, Turner Nicholas C, Piccart Martine, Vincent-Salomon Anne, Pruneri Giancarlo, Larsimont Denis, Sotiriou Christ |
| Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast cancer research : BCR 2020 3 22 (1): 28. Zundelevich Adi, Dadiani Maya, Kahana-Edwin Smadar, Itay Amit, Sella Tal, Gadot Moran, Cesarkas Karen, Farage-Barhom Sarit, Saar Efrat Glick, Eyal Eran, Kol Nitzan, Pavlovski Anya, Balint-Lahat Nora, Dick-Necula Daniela, Barshack Iris, Kaufman Bella, Gal-Yam Einav Ni |
| ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast cancer research : BCR 2020 Feb 22 (1): 16. Zundelevich Adi, Dadiani Maya, Kahana-Edwin Smadar, Itay Amit, Sella Tal, Gadot Moran, Cesarkas Karen, Farage-Barhom Sarit, Saar Efrat Glick, Eyal Eran, Kol Nitzan, Pavlovski Anya, Balint-Lahat Nora, Dick-Necula Daniela, Barshack Iris, Kaufman Bella, Gal-Yam Einav Ni |
| Impact of next-generation sequencing (NGS) for primary endocrine resistance in breast cancer patients. International journal of clinical and experimental pathology 2020 1 11 (11): 5450-5458. Li Ruoyang, Tang Tiantian, Hui Tianli, Song Zhenchuan, Li Fugen, Li Jingyu, Xu Jiaj |
| Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer. Frontiers in genetics 2021 12 662734. Hertz Daniel L, Smith Karen Lisa, Zong Yuhua, Gersch Christina L, Pesch Andrea M, Lehman Jennifer, Blackford Amanda L, Henry N Lynn, Kidwell Kelley M, Rae James M, Stearns Ver |
| DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis. Annals of translational medicine 2021 Feb 9 (3): 220. Rong Guohua, Yi Zongbi, Ma Fei, Guan Yanfang, Xu Yaping, Li Lifeng, Xu Bing |
| Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses. BMC cancer 2021 2 21 (1): 199. Huang Chi-Cheng, Tsai Yi-Fang, Liu Chun-Yu, Chao Ta-Chung, Lien Pei-Ju, Lin Yen-Shu, Feng Chin-Jung, Chiu Jen-Hwey, Hsu Chih-Yi, Tseng Ling-Mi |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences. Breast cancer research : BCR 2021 1 23 (1): 1. Priedigkeit Nolan, Ding Kai, Horne William, Kolls Jay K, Du Tian, Lucas Peter C, Blohmer Jens-Uwe, Denkert Carsten, Machleidt Anna, Ingold-Heppner Barbara, Oesterreich Steffi, Lee Adrian |
| Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Sep . Momeni Boroujeni Amir, Kertowidjojo Elizabeth, Wu Xinyu, Soslow Robert A, Chiang Sarah, Da Silva Edaise M, Weigelt Britta, Chui M Herm |
| Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Sep 28 (18): 4112-4120. Singer Christian F, , Holst Frederik, Steurer Stefan, Burandt Eike C, Lax Sigurd F, Jakesz Raimund, Rudas Margaretha, Stöger Herbert, Greil Richard, , Sauter Guido, Filipits Martin, , Simon Ronald, Gnant Michael, |
| Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR. NPJ breast cancer 2022 May 8 (1): 58. Ahn Sung Gwe, Bae Soong June, Kim Yoonjung, Ji Jung Hwan, Chu Chihhao, Kim Dooreh, Lee Janghee, Cha Yoon Jin, Lee Kyung-A, Jeong Jo |
| Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 2022 11 8 (1): 119. Qing Tao, Karn Thomas, Rozenblit Mariya, Foldi Julia, Marczyk Michal, Shan Naing Lin, Blenman Kim, Holtrich Uwe, Kalinsky Kevin, Meric-Bernstam Funda, Pusztai Laj |
| Alternating 17?-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF7. Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin, Bradley A Arrick, Grace Makari-Judson, Matthew P Goetz, Shannon M Soucy, Fred Kolling, Eugene Demidenko, Todd W Mill |
- Page last reviewed:Feb 1, 2024
- Content source: